Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
---|---|---|---|---|---|---|
Teva | Deferasirox | Deferasirox | 2022-09-23 | |||
Taro Pharmaceutical | Deferiprone | Deferiprone | 2019-02-08 | |||
Mylan | Deferasirox | Deferasirox Mylan | 2019-09-26 | |||
Deferasirox | Deferasirox | 2024-03-22 | ||||
Cipla | Deferasirox | Deferasirox | 2020-02-11 | |||
Novartis | Deferasirox | Exjade | 2005-11-02 | $647 M | Q2/19-Q2/22 | |
Deferasirox | Jadenu | 2034-11-21 | 2015-03-30 | |||
Zydus Therapeutics | Deferasirox | Deferasirox | 2020-05-05 | |||
Sun Pharmaceutical Industries | Deferasirox | Deferasirox | 2019-11-20 | |||
Alembic Pharmaceuticals | Deferasirox | Deferasirox | 2019-11-20 | |||
Alkem Laboratories | Deferasirox | Deferasirox | 2019-11-20 | |||
Jerome Stevens Pharmaceuticals | Deferasirox | Deferasirox | 2019-12-27 |
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
---|---|---|---|---|---|